Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Junshi Biosciences: Net loss of 8.75 billion yuan in 2025, compared with a net loss of 12.81 billion yuan in the same period last year.
Junshi Biosciences announces that in 2025, operating revenue will be 2.5B yuan, a year-on-year increase of 28.23%; net loss attributable to shareholders of the listed company will be 875 million yuan, compared to a net loss of 1.28B yuan in the same period last year. The company’s profit distribution plan for 2025 is: no profit distribution will be made, and no capital reserve will be converted into share capital.